Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Ophthalmic play Kala raises $68M in series C

    Kala Pharmaceuticals Inc. (Waltham, Mass.) raised $68 million in a series C round led by new investor Longitude Capital. New investors included OrbiMed, Vivo Capital and CAM Capital also participated, along with …

    Published on 4/13/2016
  • FINANCIAL NEWS: Financial tracks

    Versant Ventures promoted Jerel Davis to managing director from partner, and Carlo Rizzuto to partner from venture partner. The firm also hired Luca Santarelli as a venture partner. He was SVP and global head of …

    Published on 4/12/2016
  • FINANCIAL NEWS: Forbion closes third life sciences fund

    Forbion Capital Partners closed its third life sciences fund, Forbion Capital Fund III, at EUR 183 million ($208.2 million). The fund's LPs include the European Investment Fund, Dutch Venture Initiative, KfW, Charles …

    Published on 4/12/2016
  • FINANCIAL NEWS: MedDay raises EUR 34M in series B

    MedDay S.A.S. (Paris, France) raised EUR 34 million ($38.7 million) in a series B round led by new investor Edmond de Rothschild Investment Partners. Sofinnova Partners and the InnoBio and Large Venture funds of …

    Published on 4/8/2016
  • FINANCIAL NEWS: Aeglea raises $50M in IPO

    Aeglea Biotherapeutics Inc. (NASDAQ:AGLE) shed $0.23 to $9.77 in its first day of trading Thursday after it raised $50 million through the sale of 5 million shares at $10 in an IPO underwritten by UBS, BMO Capital …

    Published on 4/7/2016
  • FINANCIAL NEWS: Alder raises $125M in follow-on

    Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) raised $125 million through the sale of 5.4 million shares at $23.25 in a follow-on underwritten by JPMorgan, Leerink and Wells Fargo.Alder proposed after market close …

    Published on 4/7/2016
  • FINANCIAL NEWS: Biotech stocks surge

    Biotech stocks posted their biggest single-day gain in more than four years on Wednesday as the BioCentury 100 Index rose 306.30 (6.3%) to 5,153.79. Gainers outnumbered decliners 99-1.Other biotech indices also posted …

    Published on 4/6/2016
  • FINANCIAL NEWS: Orphan play Lumos raises $34M

    Lumos Pharma Inc. (Austin, Texas) raised $34 million in a series B round led by new investor Deerfield Management. New investors Clarus Ventures and Roche Venture Fund also participated, as did existing investors New …

    Published on 4/6/2016
  • FINANCIAL NEWS: Allergan, Pfizer won't speculate on new inversion rules

    Allergan plc (NYSE:AGN) lost $41 (15%) to $236.55 and Pfizer Inc. (NYSE:PFE) gained $0.64 to $31.36 on Tuesday, a day after the U.S. Treasury issued temporary regulations on tax inversions that could affect the …

    Published on 4/5/2016
  • FINANCIAL NEWS: Allergan sinks after Treasury revises inversion rules

    Allergan plc (NYSE:AGN) sank $60.55 (22%) to $217 in early after-hours trading Monday after the U.S. Treasury issued temporary regulations on tax inversions that could affect the company's pending merger with Pfizer Inc…

    Published on 4/4/2016
  • FINANCIAL NEWS: Antibacterial play Entasis raises $50M series B

    Entasis Therapeutics Inc. (Waltham, Mass.) raised $50 million in a series B round led by new investor Clarus Ventures. Frazier Healthcare Partners, Novo A/S (Hellerup, Denmark) and Eventide Funds also participated. …

    Published on 4/4/2016
  • FINANCIAL NEWS: Human Longevity raises $220M series B

    Human Longevity Inc. (San Diego, Calif.) raised $220 million in a series B financing that included Illumina Inc. (NASDAQ:ILMN), Celgene Corp. (NASDAQ:CELG) and GE Ventures. Human Longevity said its series A investors …

    Published on 4/4/2016
  • FINANCIAL NEWS: Metabomed caps $18M series A

    Cancer play Metabomed Ltd. (Yavne, Israel) said it raised an undisclosed amount in an extension of its series A round, bringing the round's total to $18 million. New investors Pfizer Inc. (NYSE:PFE) and Arkin Holdings …

    Published on 4/4/2016
  • FINANCIAL NEWS: Anacor raises $250M in note deal

    Anacor Pharmaceuticals Inc. (NASDAQ:ANAC) raised $250 million in a private placement of senior convertible notes. The unsecured notes bear 2% interest, mature in 2023 and initially convert at $70.82, which is a 21% …

    Published on 4/1/2016
  • FINANCIAL NEWS: Burrill settles with SEC, accepts permanent ban

    G. Steven Burrill and two other members of Burrill Capital Management's team agreed to be barred permanently from the securities industry to settle an SEC investigation into Burrill's alleged embezzlement from the 2006-…

    Published on 3/31/2016
  • FINANCIAL NEWS: Antibiotic play Zavante raises $45M

    Zavante Therapeutics Inc. (San Diego, Calif.) raised $45 million in a series A round co-led by Frazier Healthcare Partners and Longitude Capital. Aisling Capital also participated. The round comprised $35 million in new…

    Published on 3/30/2016
  • FINANCIAL NEWS: Gadeta raises EUR 7M for T cell therapies

    Gadeta B.V. (Utrecht, the Netherlands) raised EUR 7 million ($7.8 million) in a series A round led by Baxalta Ventures and Medicxi Ventures. Gadeta's founders, management and Utrecht Holdings also participated. Gadeta …

    Published on 3/29/2016
  • FINANCIAL NEWS: Organ-on-chip play Emulate raises $28M

    Emulate Inc. (Boston, Mass.) raised $28 million in a series B round. The company plans to expand its Organ-Chip portfolio and commercialize its Human Emulation System.New investors included OS Fund, Atel Ventures, and …

    Published on 3/28/2016
  • FINANCIAL NEWS: Quaker's Gavin passes away

    Brenda Gavin, a founding partner at Quaker Partners, passed away March 17. She co-founded the firm in 2002 with Sherrill Neff. Previously, she was president of the S.R. One venture arm of GlaxoSmithKline plc (LSE:GSK; …

    Published on 3/28/2016
  • FINANCIAL NEWS: Anti-infective play Iterum debuts with $40M

    Iterum Therapeutics Ltd. (Dublin, Ireland) raised $40 million in a series A round led by Frazier Healthcare Partners. Canaan Partners, Sofinnova Ventures and New Leaf Venture Partners also participated. The newco also …

    Published on 3/24/2016
  • FINANCIAL NEWS: Frazier closes $525M growth buyout fund

    Frazier Healthcare Partners closed its Frazier Healthcare Growth Buyout Fund VIII at $525 million. It is the firm's first fund dedicated to growth buyouts of profitable healthcare companies.Frazier said the fund …

    Published on 3/24/2016
  • FINANCIAL NEWS: Paul Allen to invest $100M in biotech

    Philanthropist Paul Allen said he will invest $100 million in bioscience over 10 years via the Paul G. Allen Frontiers Group, a new investment vehicle. The group committed $10 million over four years to each of two …

    Published on 3/24/2016
  • FINANCIAL NEWS: SillaJen raises $37M in venture round

    SillaJen Inc. (Busan, South Korea) raised $37 million in a venture round, including $12 million from Medivate Partners. SillaJen VP of Product and Alliance Management Robin Scully told BioCentury that Hana Financial …

    Published on 3/24/2016
  • FINANCIAL NEWS: Vitae raises $35M in follow-on

    Vitae Pharmaceuticals Inc. (NASDAQ:VTAE) raised $35 million through the sale of 5.8 million shares at $6 in a follow-on underwritten by Piper Jaffray, BMO Capital Markets and Wedbush PacGrow. It proposed the offering …

    Published on 3/24/2016
  • FINANCIAL NEWS: Celator raises $38M in follow-on

    Celator Pharmaceuticals Inc. (NASDAQ:CPXX) raised $38 million through the sale of 4 million shares at $9.50 in a follow-on underwritten by Stifel, Needham, Roth Capital Partners, H.C. Wainwright and National Securities.…

    Published on 3/23/2016

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993